Aton Biotech, a CDMO committed to enabling new biological drugs for clients with an integrated bio-pharmaceutical platform, and KangaBio have announced a Strategic Collaboration. Both parties aim to share resources and achieve joint development on the principle of equality and mutual benefits. Aton Biotech will provide CDMO services for the innovative drugs of KangaBio, which […]

The post KangaBio and Aton Biotech Enter Into Development and Manufacturing Strategic Collaboration first appeared on World Pharma Today.